WO2013051556A1 - 飲料組成物 - Google Patents
飲料組成物 Download PDFInfo
- Publication number
- WO2013051556A1 WO2013051556A1 PCT/JP2012/075505 JP2012075505W WO2013051556A1 WO 2013051556 A1 WO2013051556 A1 WO 2013051556A1 JP 2012075505 W JP2012075505 W JP 2012075505W WO 2013051556 A1 WO2013051556 A1 WO 2013051556A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- beverage composition
- beverage
- collagen peptide
- less
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 76
- 102000008186 Collagen Human genes 0.000 claims abstract description 66
- 108010035532 Collagen Proteins 0.000 claims abstract description 66
- 229920001436 collagen Polymers 0.000 claims abstract description 66
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 62
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 49
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract description 31
- 235000013361 beverage Nutrition 0.000 claims description 81
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 27
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- 239000008123 high-intensity sweetener Substances 0.000 claims description 11
- 235000013615 non-nutritive sweetener Nutrition 0.000 claims description 11
- 150000001413 amino acids Chemical class 0.000 claims description 10
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 9
- 235000015165 citric acid Nutrition 0.000 claims description 9
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 8
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 7
- 239000004472 Lysine Substances 0.000 claims description 7
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 7
- 229960005070 ascorbic acid Drugs 0.000 claims description 7
- 239000011975 tartaric acid Substances 0.000 claims description 7
- 235000002906 tartaric acid Nutrition 0.000 claims description 7
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 6
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 6
- 239000011668 ascorbic acid Substances 0.000 claims description 6
- 235000010323 ascorbic acid Nutrition 0.000 claims description 6
- 239000001630 malic acid Substances 0.000 claims description 6
- 235000011090 malic acid Nutrition 0.000 claims description 6
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 5
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 5
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 5
- 239000004376 Sucralose Substances 0.000 claims description 5
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 5
- 229960004998 acesulfame potassium Drugs 0.000 claims description 5
- 239000000619 acesulfame-K Substances 0.000 claims description 5
- 235000019408 sucralose Nutrition 0.000 claims description 5
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 5
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 4
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 4
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 4
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 4
- 239000001530 fumaric acid Substances 0.000 claims description 4
- 235000011087 fumaric acid Nutrition 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 229960003104 ornithine Drugs 0.000 claims description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 4
- 108010011485 Aspartame Proteins 0.000 claims description 3
- 244000228451 Stevia rebaudiana Species 0.000 claims description 3
- 239000000605 aspartame Substances 0.000 claims description 3
- 235000010357 aspartame Nutrition 0.000 claims description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 3
- 229960003438 aspartame Drugs 0.000 claims description 3
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 3
- 239000000892 thaumatin Substances 0.000 claims description 3
- 235000010436 thaumatin Nutrition 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 abstract description 31
- 235000019634 flavors Nutrition 0.000 abstract description 31
- 238000000034 method Methods 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 11
- 235000003599 food sweetener Nutrition 0.000 description 11
- 239000003765 sweetening agent Substances 0.000 description 11
- 238000002156 mixing Methods 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 9
- 241000251468 Actinopterygii Species 0.000 description 8
- 235000019688 fish Nutrition 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 230000007794 irritation Effects 0.000 description 7
- -1 sodium metaphosphate Chemical class 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 230000002421 anti-septic effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 235000018977 lysine Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000004386 Erythritol Substances 0.000 description 4
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 230000003139 buffering effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000019414 erythritol Nutrition 0.000 description 4
- 229940009714 erythritol Drugs 0.000 description 4
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000010979 pH adjustment Methods 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 235000019983 sodium metaphosphate Nutrition 0.000 description 3
- 150000005846 sugar alcohols Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- SERLAGPUMNYUCK-YJOKQAJESA-N 6-O-alpha-D-glucopyranosyl-D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-YJOKQAJESA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000269908 Platichthys flesus Species 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000276438 Gadus morhua Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- XJCCHWKNFMUJFE-CGQAXDJHSA-N Maltotriitol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H](O)[C@@H](O)CO)[C@H](O)CO)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 XJCCHWKNFMUJFE-CGQAXDJHSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 235000015742 Nephelium litchi Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 241000276707 Tilapia Species 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 210000004666 bacterial spore Anatomy 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 241001233037 catfish Species 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
Definitions
- the present invention relates to a beverage composition.
- Collagen is an animal protein conventionally used in the food field as gelatin. However, since it is the main component of the dermis and connective tissue, it has recently attracted particular attention from the medical and beauty fields. ing. In addition, in order to efficiently use ingested collagen in the body, food and drink containing collagen peptides in which high molecular weight collagen is reduced have been developed. Furthermore, in order to obtain a high effect, beverages containing 10,000 mg of collagen peptide per bottle are becoming mainstream. A beverage using such a collagen peptide has a problem from the viewpoint of palatability due to the smell unique to the collagen peptide. In particular, when 10,000 mg of collagen peptide is added per bottle, the concentration of the collagen peptide becomes higher than usual, so that the odor is particularly emphasized.
- Patent Document 1 discloses a beverage containing various nutrients including collagen hydrolyzate, two or more extracts including barley extract, and sourness. A technique for realizing a health drink having a good flavor by using an agent, a fruit flavor and the like is disclosed.
- Patent Document 2 describes that in addition to collagen peptides, fruit juice and phosphoric acid or phosphate A technique using is disclosed.
- fruit juice such as grape concentrate juice and a phosphate such as sodium metaphosphate are blended to obtain a liquid oral composition that suppresses unpleasant odor, has a good flavor, and has excellent storage stability.
- beverages containing such collagen peptides are classified as soft drinks and are heat-treated for sterilization purposes.
- the conditions for sterilization are largely distinguished by the pH of the beverage.
- yeast or mold In the acidic region, yeast or mold is used, and in the neutral pH region, bacterial spores are targeted for sterilization.
- the food hygiene law in Japan has no storage standards and requires sterilization.
- sterilization of those with a pH of less than 4.0 is performed by heating the center temperature at 65 ° C. for 10 minutes or a method equivalent to or higher, pH 4.0 to
- the sterilization of 4.6 is described as a method of heating at 85 ° C. for 30 minutes or a method equivalent to or higher, and the pH of the beverage itself is kept low for the purpose of imparting antiseptic properties to the beverage and making it a safe beverage.
- Patent Document 3 discloses a beverage adjusted to pH 4.0 or lower using citric acid or ascorbic acid.
- the viscosity of the beverage is optimally maintained for the purpose of improving the texture (effect / satisfaction when contained in the mouth) of the beverage cooled in the refrigerator and kept at room temperature, such as yogurt
- a technique for imparting a flavor with the flavor of the present invention is disclosed.
- collagen peptides are known to have pH buffering ability.
- the pH buffering ability of the collagen peptide cannot be ignored.
- the amount of acidulant used becomes excessive and the acidity is strongly felt, and the flavor is impaired. It has been found that there is a harmful effect of being. Therefore, the present invention provides a beverage composition that has a high concentration of collagen peptide and realizes a moderate acidity and a good flavor in a pH range of pH 4.0 or less, which is effective for preservability. Let it be an issue.
- the present invention is as follows.
- the acidulant contains phosphoric acid and at least one selected from the group consisting of citric acid, tartaric acid, malic acid, ascorbic acid, lactic acid, succinic acid, and fumaric acid [1] or [ 2].
- a packaged beverage comprising the beverage composition according to any one of [1] to [5].
- a beverage composition containing a high concentration of collagen peptide and having an appropriate acidity and good flavor in a pH range of pH 4.0 or lower.
- the beverage composition according to the present invention contains a low molecular collagen peptide having an average molecular weight of 3000 or less of 2000 mg / 10 mL or more and two or more acidulants containing phosphoric acid, and has a pH of 4.0 or less. It is a thing.
- a low molecular collagen peptide having a predetermined average molecular weight is contained at a high concentration of 2000 mg / 10 mL or more, and as a sour agent, phosphoric acid and other sour agents are contained, so that the pH is 4.0 or less. Even if it exists, the collagen peptide drink composition which has moderate acidity and favorable flavor can be provided.
- a part of the sour agent is phosphoric acid, so that the beverage composition contains a low molecular collagen peptide having an average molecular weight of 3000 or less at a high concentration of 2000 mg / 10 mL or more.
- the product is adjusted to pH 4.0 or lower, even if the collagen peptide has a pH buffering ability, it is possible to suppress excessive acidity and maintain antiseptic properties.
- the term “process” is not limited to an independent process, and is included in this term if the intended action of this process is achieved even when it cannot be clearly distinguished from other processes. .
- a numerical range indicated by using “to” indicates a range including the numerical values described before and after “to” as the minimum value and the maximum value, respectively.
- the amount or concentration of each component in the composition when there are a plurality of substances corresponding to each component in the composition, they exist in the composition unless otherwise specified. It means the total amount of the plurality of substances. The present invention will be described below.
- the collagen peptide is a low molecular weight collagen peptide having an average molecular weight of 3000 or less. By setting the average molecular weight to 3000 or less, there is a tendency that the absorbability of the collagen peptide when ingested as a food or drink is increased, and that a large difference in viscosity between room temperature and refrigeration can be avoided.
- the average molecular weight of the collagen peptide is preferably 500 to 3000, and more preferably 1000 to 3000. There exists a tendency for the viscosity which has a preferable texture to be obtained by making an average molecular weight 500 or more.
- the average molecular weight of the collagen peptide means a value measured by gel permeation chromatography (GPC: polyethylene glycol (PEG) standard). In the case of a commercial product, the product information provided by the supplier is used. Good. In order to obtain the average molecular weight by GPC, the molecular weight is calculated based on a calibration curve of the relationship between the retention time and the molecular weight obtained by measuring several kinds of polyethylene glycol (PEG) having different molecular weights in advance under the same conditions.
- the average molecular weight in the present invention refers to a weight average molecular weight calculated in terms of PEG according to this method.
- the collagen peptide is obtained by hydrolyzing gelatin with an enzyme or an acid, is a protein containing a large amount of glycine, and is also available as a commercial product.
- the collagen is not particularly limited, whether it is collagen extracted from mammalian collagen tissue or collagen extracted from fish. In recent years, collagen derived from fish is preferable from the viewpoints of product image and safety.
- the raw material for collagen derived from fish may be saltwater fish or freshwater fish, and skins of tuna (sharkfin), shark, cod, flounder, flounder, Thailand, tilapia, salmon, catfish and the like.
- These collagens derived from fish are extracted from fish scales and skins, and are characterized by a low content of proline, lysine, and the like compared to collagen of humans and other animals.
- Examples of the raw material for mammal-derived collagen include pigs and cows.
- the concentration of the collagen peptide is 2000 mg / 10 mL or more. By setting it to 2000 mg / 10 mL or more, the collagen peptide can be efficiently used in the body.
- the collagen peptide concentration is not particularly limited as long as it is 2000 mg / 10 mL or more with respect to the volume of the beverage composition, but is preferably 2000 mg / 10 mL or more to 4000 mg / 10 mL, more preferably 2500 mg / 10 mL to 3500 mg / 10 mL. By setting it as 4000 mg / 10mL or less, it can be set as the viscosity within the range acceptable as a drink.
- the beverage composition contains two or more acidulants containing phosphoric acid.
- pH of a solution can be 4.0 or less, suppressing acidity, and moderate acidity and favorable flavor can be implement
- the phosphoric acid which can be used in the said drink composition can be used as food-drinks, it can be especially used without a restriction
- phosphates such as sodium metaphosphate
- the pH of the beverage composition cannot be adjusted to 4.0 or lower while maintaining an appropriate acidity and good flavor.
- the concentration of phosphoric acid in the beverage composition is preferably 20 mg / 10 mL to 200 mg / 10 mL, more preferably 25 mg / 10 mL to 130 mg / 10 mL with respect to the volume of the beverage composition.
- moderate acidity to be obtained by setting it as 20 mg / 10mL or more, and there exists a tendency which is easy to suppress unnatural bitterness by setting it as 200 mg / 10mL or less.
- the acidulant other than phosphoric acid is not particularly limited as long as it is an acidulant that can be used for beverages, particularly an acidulant suitable for use in soft drinks.
- Acetic acid, gluconic acid, citric acid, tartaric acid, apple Acid, ascorbic acid, lactic acid, succinic acid, fumaric acid and the like can be used.
- the acidulant capable of realizing a preferred flavor in the present invention is citric acid, tartaric acid, malic acid, ascorbic acid, lactic acid, succinic acid, or fumaric acid, and in particular, the balance between irritation and refreshing feeling as a beverage
- Citric acid, tartaric acid, malic acid, or ascorbic acid is more preferable from the viewpoint, and citric acid, tartaric acid, or malic acid is still more preferable from the viewpoint of pH adjustment ability.
- These acidulants other than phosphoric acid may be used singly or in combination of two or more.
- the concentration of the acidulant other than phosphoric acid in the beverage composition is preferably 10 mg / 10 mL to 800 mg / 10 mL, more preferably 20 mg / 10 mL to 350 mg / 10 mL with respect to the volume of the beverage composition.
- concentration of the acidulant other than phosphoric acid in the beverage composition is preferably 10 mg / 10 mL to 800 mg / 10 mL, more preferably 20 mg / 10 mL to 350 mg / 10 mL with respect to the volume of the beverage composition.
- the total amount of the acidulant containing phosphoric acid can be changed according to the concentration of the collagen peptide.
- the concentration of the collagen peptide is 2000 mg / 10 mL or more, and the collagen peptide in this concentration range has a strong pH buffering capacity as described above.
- the total amount of acidulant can be set as appropriate.
- the total amount of the acidulant containing phosphoric acid is preferably 50 mg / 10 mL to 600 mg / 10 mL, more preferably 80 mg / 10 mL to 500 mg / 10 mL, and 100 mg / 10 mL with respect to the volume of the beverage composition. More preferably, it is ⁇ 400 mg / 10 mL.
- the phosphoric acid content may be set within the range of 9% to 85% by weight of the total acidulant, for example. it can.
- the beverage composition preferably contains at least one amino acid selected from the group consisting of lysine, proline and ornithine.
- Lysine, proline and ornithine which are types of amino acids, are known as collagen components or collagen synthesis promoting components, and by adding these additional amino acids in the body, the production efficiency and utilization efficiency of collagen in the body Is expected to increase further.
- only the L-form is used for the amino acid used in this invention.
- the amino acid is preferably used in combination in order to increase the effective use efficiency of collagen, and among them, lysine is more preferably used.
- the concentration of the amino acid in the beverage composition is preferably 10 mg / 10 mL to 200 mg / mL, more preferably 30 mg / 10 mL to 100 mg / mL with respect to the volume of the beverage composition. If the concentration of the amino acid is 10 mg / 10 mL or more, the collagen peptide tends to be used effectively, and if it is 200 mg / 10 mL or less, the flavor peculiar to amino acids can be suppressed.
- the beverage composition preferably contains at least one selected from the group consisting of high-intensity sweeteners and sweeteners other than high-intensity sweeteners in order to adjust the beverage to a more preferred flavor.
- the high-intensity sweetener is a general term for a synthetic sweetener or a natural sweetener having a sweetness several tens to several thousand times that of sugar.
- the high-intensity sweetener there is no limitation as long as the flavor can be preferably adjusted, but in the present invention, aspartame, thaumatin, stevia, sucralose, or acesulfame potassium can be preferably used, and further, acesulfame potassium, Or sucralose is preferable.
- the said high sweetness degree sweetener may be used individually by 1 type, and may be used in combination of 2 or more type.
- the concentration of the high-intensity sweetener in the beverage composition is preferably 1 mg / 10 mL to 50 mg / 10 mL, and more preferably 3 mg / 10 mL to 25 mg / 10 mL. If it is 1 mg / 10mL or more, there exists a tendency which can implement
- sweetener other than the high-intensity sweetener examples include saccharides, sugar alcohols and powdered sugar.
- saccharide examples include monosaccharides such as glucose, fructose, galactose and isomerized sugar; disaccharides such as sugar, lactose and palatinose; oligosaccharides such as fructo-oligosaccharide, isomaltooligosaccharide and galactooligosaccharide.
- sugar alcohol examples include monosaccharide alcohols such as erythritol, xylitol, sorbitol, and mannitol; disaccharide alcohols such as maltitol, isomaltitol, and lactitol; trisaccharide alcohols such as maltotriitol, isomaltitol, and panitol. Alcohols such as oligosaccharide alcohols; sugar alcohols such as powdered reduced maltose starch syrup and the like. As the sweetener, glucose, powdered sugar, erythritol, xylitol and sorbitol are more preferable, and erythritol is most preferable. These sweeteners may be used alone or in combination of two or more.
- the concentration of the sweetener other than the high-intensity sweetener in the beverage composition is preferably 100 mg / 10 mL to 5000 mg / 10 mL, and more preferably 300 mg / 10 mL to 2500 mg / 10 mL.
- the said sweetener may be used individually by 1 type, and may be used in combination of 2 or more type.
- the said drink composition may use the said high sweetness degree sweetener and other sweeteners each independently, and may use these in combination.
- a high-intensity sweetener and a sweetener other than the high-intensity sweetener can be used in combination.
- the beverage composition may preferably further contain a fragrance.
- a fragrance of any of yogurt, sugar, lychee, peach, mango, pineapple, raspberry, blueberry, cranberry, and pear is preferable.
- the concentration of the flavor in the beverage composition is preferably 10 ⁇ L / 10 mL to 200 ⁇ L / 10 mL, more preferably 30 ⁇ L / 10 mL to 100 ⁇ L / 10 mL.
- the beverage composition may contain a functional oily component.
- the functional oily component means an oily component that, when applied to a living body, can be expected to induce a predetermined physiological effect in the applied living body.
- Examples of the functional oil component include carotenoids such as ⁇ -carotene, astaxanthin, lutein, lycopene; linolenic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), squalene, squalane, fish oil containing these, and the like Of unsaturated fatty acids; coenzyme Q10 and the like.
- the beverage composition may contain other additive components.
- additive components include various vitamins, minerals, colorants, antioxidants, stabilizers, preservatives, emulsifiers, and antifoaming agents.
- the viscosity of the beverage composition is preferably in the range of 10 mPa ⁇ s to 35 mPa ⁇ s at room temperature (25 ° C.), and in the range of 20 mPa ⁇ s to 50 mPa ⁇ s at 4 ° C. Within this range, it is desirable to realize a good texture even when drinking at room temperature or when refrigerated. By setting it to 10 mPa ⁇ s at room temperature or 20 mPa ⁇ s or higher at 4 ° C., there is a tendency that the viscosity does not become excessively dry and sufficient satisfaction is obtained as a texture when eaten.
- the viscosity of the beverage composition can be measured with a rotary viscometer.
- the pH of the beverage composition is 4.0 or less. Above pH 4.0, the antiseptic effect is reduced. In addition, in the case of a beverage composition exceeding pH 4.0, a stronger heat treatment is required in the production process according to the Food Sanitation Law, and the flavor tends to be impaired and the components tend to deteriorate.
- the pH of the beverage composition is preferably 3.0 to 4.0, and more preferably pH 3.4 to 4.0. By setting the pH to 3.0 or more, there is a tendency that an increase in the amount of acidulant used for pH adjustment can be suppressed.
- the method for producing the beverage composition comprises mixing 2000 mg / 10 mL or more of a low molecular collagen peptide having an average molecular weight of 3000 or less and two or more acidulants containing phosphoric acid (mixing step), and adjusting the pH. It includes adjusting to 4.0 or less (pH adjusting step). Thereby, the said drink composition concerning this invention mentioned above can be prepared.
- the mixing step includes mixing each component constituting the beverage composition.
- Each component may be mixed with a preferred aqueous medium.
- aqueous medium water is usually used.
- the mixing of each component is not particularly limited, and is carried out at a temperature at which each component is sufficiently dissolved, for example, within a temperature range of 20 ° C. to 80 ° C.
- the mixing is preferably performed with stirring.
- the pH adjustment step may be performed simultaneously with the mixing step. Good. Moreover, the said pH adjustment process may be performed separately after a mixing process as needed.
- the method for producing the beverage composition may include other steps other than those described above, if necessary. As such an additional process, a viscosity adjustment process, a filtration process, etc. can be mentioned. A known method in the art may be applied to the viscosity adjustment step and the filtration step.
- the beverage composition may be a packaged beverage containing the composition.
- the container-packed beverage is obtained by container-packing the beverage composition.
- a container used for this container-packed drink what is normally used as a container for drinks should just be mentioned, for example, a PET bottle, a paper pack, a glass container, an aluminum can, a steel can, a pouch etc. are mentioned. it can.
- Example 1 L-lysine 200 mg, erythritol 1000 mg, sucralose 7.2 mg, acesulfame potassium 8.4 mg are added to collagen peptide 10000 mg having an average molecular weight of 2700, L-ascorbic acid 400 mg, citric acid 250 mg, L-tartaric acid 350 mg, phosphoric acid 130 mg was added. 15 mL of water was added thereto and dissolved by heating at 50 ° C., and after adding a fragrance after dissolution, additional water was added to adjust the total volume to 30 mL to prepare a beverage composition. It was 3.88 when pH of the obtained drink composition was measured.
- Examples 2 to 47 A beverage composition was prepared in the same manner as in Example 1 except that the ingredients and blending amounts were changed as shown in Tables 1, 2, 5, and 7.
- Example 1 A beverage composition was prepared in the same manner as in Example 1 except that each material and blending amount were changed as shown in Table 3, Table 4, Table 6, and Table 8.
- ⁇ * 1 indicates a slight bite to the tongue, but it means that the flavor is good, and “ ⁇ * 2” indicates a slight lack of refreshment and irritation. However, it means that the flavor is good. “ ⁇ * 1” means that a sour taste accompanied by a pungent taste is felt but allowed. In addition, “ ⁇ * 1” means that there is little refreshing feeling and irritation and it is too light, and “ ⁇ * 2” means that it feels slightly refreshing and irritation and feels slightly bitter. To do. “-” Means that the evaluation is not performed because the pH exceeds 4.0.
- the beverage composition containing 3333 mg / 10 mL of collagen peptide and containing phosphoric acid and other acidulant and having a pH of 4.0 or less was used in Examples 1 to 23 Were all beverage compositions with moderate acidity and good flavor. Further, it was confirmed that the flavors of the beverage compositions of Examples 1 to 7 and 11 to 23 containing at least one of citric acid, tartaric acid, and malic acid as an acidulant other than phosphoric acid were better. It was done.
- Comparative Examples 1 to 7 and 13 to 17 were unsuitable from the viewpoint of antiseptic properties because the pH exceeded 4.0.
- a phosphate such as sodium metaphosphate
- Comparative Examples 13 to 17 using a phosphate such as sodium metaphosphate the same amount of phosphoric acid is used, and the same amount of other acidulant when pH 4.0 or lower is used in combination with the same amount.
- Comparative Example 11 and Comparative Example 12 using only phosphoric acid as an acid for adjusting pH have a flavor lacking in a refreshing feeling
- Comparative Examples 8 to 10 and 18 to 21 not using phosphoric acid have a sour taste. Irritation was increased and a favorable flavor could not be obtained.
- a beverage composition containing a high concentration of collagen peptide and having an appropriate acidity and good flavor in a pH range of 4.0 or less can be obtained.
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cereal-Derived Products (AREA)
Abstract
Description
このようなコラーゲンペプチドを用いた飲料には、コラーゲンペプチド独特の臭みを有することに起因した嗜好性の観点での課題が存在する。特に、一本当たり10,000mgのコラーゲンペプチドを配合した場合は、コラーゲンペプチドの濃度が通常よりも高くなることから、特に臭みが強調される。
従って、本発明においては、高濃度のコラーゲンペプチドを含有し、且つ防腐性に効果のあるpH4.0以下のpH範囲において、適度な酸味と良好な風味を実現した飲料組成物を提供することを課題とする。
[1] 平均分子量が3000以下の低分子コラーゲンペプチド2000mg/10mL以上と、リン酸を含む2種以上の酸味料と、を含有し、pHが4.0以下の飲料組成物。
[2] 前記リン酸の濃度が、前記組成物の容量に対して、20mg/10mL~200mg/10mLである[1]に記載の飲料組成物。
[3] 前記酸味料が、リン酸と、クエン酸、酒石酸、リンゴ酸、アスコルビン酸、乳酸、コハク酸、及びフマル酸からなる群より選択された少なくとも1種とを含有する[1]又は[2]に記載の飲料組成物。
[4] リジン、プロリン及びオルニチンからなる群より選択された少なくとも1種のアミノ酸を含有する[1]~[3]のいずれかに記載の飲料組成物。
[5] アスパルテーム、ソーマチン、ステビア、スクラロース、及びアセスルファムカリウムからなる群より選択された少なくとも1種の高甘味度甘味料を含む[1]~[4]のいずれかに記載の飲料組成物。
[6] [1]~[5]のいずれか記載の飲料組成物を含む容器詰飲料。
本発明によれば、所定の平均分子量を有する低分子コラーゲンペプチドを2000mg/10mL以上という高濃度で含み、且つ、酸味料として、リン酸と他の酸味料とを含むので、pH4.0以下であっても、適度な酸味と良好な風味とを有するコラーゲンペプチド飲料組成物を提供することができる。
これを詳細に説明すれば、前記飲料組成物では、酸味料の一部をリン酸とすることで、平均分子量が3000以下の低分子コラーゲンペプチドを2000mg/10mL以上の高濃度で含有した飲料組成物をpH4.0以下に調整した場合に、コラーゲンペプチドがpH緩衝能を有しているとしても、過剰な酸味を抑え、かつ防腐性を維持することが可能となる。
また、本発明において「~」を用いて示された数値範囲は、「~」の前後に記載される数値をそれぞれ最小値及び最大値として含む範囲を示す。
また、本発明において、組成物中の各成分の量又は濃度について言及する場合、組成物中に各成分に該当する物質が複数存在する場合には、特に断らない限り、組成物中に存在する当該複数の物質の合計量を意味する。
以下、本発明について説明する。
GPCで平均分子量を求めるには、あらかじめ分子量が既知で異なるポリエチレングリコール(PEG)数種を同条件で測定して得られたリテンションタイムと分子量の関係の検量線を元に算出する。本発明における平均分子量とは、この手法に従ってPEG換算で算出した重量平均分子量を指す。
前記飲料組成物におけるリン酸の濃度としては、前記飲料組成物の容量に対して20mg/10mL~200mg/10mLが好ましく、25mg/10mL~130mg/10mLがより好ましい。20mg/10mL以上とすることにより、適度な酸味が得られる傾向があり、200mg/10mL以下とすることにより、不自然な苦みを抑えやすい傾向がある。
前記飲料組成物における前記高甘味度甘味料の濃度としては、1mg/10mL~50mg/10mLが好ましく、3mg/10mL~25mg/10mLがより好ましい。1mg/10mL以上であれば、適度な甘味を実現できる傾向があり、50mg/10mL以下であれば、適度な風味を実現できる傾向がある。
また、前記飲料組成物は、前記高甘味度甘味料及びそれ以外の甘味料をそれぞれ単独で使用してもよく、これらを組み合わせて使用してもよい。前記飲料組成物としては、好ましくは、高甘味度甘味料、及び高甘味度甘味料以外の甘味料を併用して用いることができる。
前記飲料組成物における前記香料の濃度としては、10μL/10mL~200μL/10mLが好ましく、30μL/10mL~100μL/10mLがより好ましい。
なお、前記飲料組成物の粘度は、回転式粘度計により測定することができる。
これにより、前述した本発明にかかる前記飲料組成物を調製することができる。
[実施例1]
平均分子量2700のコラーゲンペプチド10000mgに、L-リジン200mg、エリスリトール1000mg、スクラロース7.2mg、アセスルファムカリウム8.4mgを加え、更にL-アスコルビン酸を400mg、クエン酸250mg、L-酒石酸350mg、リン酸130mgを加えた。これに水を15mL加え50℃で加温溶解し、溶解後に香料を加えたのち追加で水を加え、全体の容量を30mLに調整し、飲料組成物を調製した。
得られた飲料組成物のpHを測定したところ、3.88であった。
各素材及び配合量を表1、表2、表5及び表7に示すように変更した以外は全て実施例1と同様の手順で飲料組成物を調製した。
各素材及び配合量を表3、表4、表6及び表8に示すように変更した以外は全て実施例1と同様の手順で飲料組成物を調製した。
実施例1~47および比較例1~44の飲料組成物について、25℃においてpHを測定した。結果を表1~表8に示す。
実施例1~47および比較例1~44の飲料組成物について、pHが4.0以下であったものについて風味の評価を行った。
風味評価は、実施例及び比較例の各飲料を試飲し、酸味の清涼感及び刺激の観点で風味を官能評価した。非常に良好であれば◎◎、清涼感がやや不足だが良好であれば◎、良であれば○、許容されるレベルであれば△、製品として問題がある場合には×と評価した。
結果を表1~表8に示した。なお、表1~表8中「○*1」は、やや舌に刺さる感じがあるが、風味としては良であることを意味し、「○*2」は、清涼感、刺激がやや不足しているが風味としては良であることを意味する。「△*1」は、辛味を伴う酸味を感じるが、許容されることを意味する。また、「×*1」は、清涼感、刺激が少なく、あっさりしすぎていることを意味し、「×*2」は、清涼感、刺激が少なく、やや苦っぽさを感じることを意味する。「-」は、pHが4.0を超えているため評価していないことを意味する。
Claims (6)
- 平均分子量が3000以下の低分子コラーゲンペプチド2000mg/10mL以上と、
リン酸を含む2種以上の酸味料と、
を含有し、
pHが4.0以下である、飲料組成物。 - 前記リン酸の濃度が、前記組成物の容量に対して、20mg/10mL~200mg/10mLである、請求項1に記載の飲料組成物。
- 前記酸味料が、リン酸と、クエン酸、酒石酸、リンゴ酸、アスコルビン酸、乳酸、コハク酸、及びフマル酸からなる群より選択された少なくとも1種とを含有する、請求項1又は請求項2記載の飲料組成物。
- リジン、プロリン及びオルニチンからなる群より選択された少なくとも1種のアミノ酸を含有する、請求項1~3のいずれか一項に記載の飲料組成物。
- アスパルテーム、ソーマチン、ステビア、スクラロース、及びアセスルファムカリウムからなる群より選択された少なくとも1種の高甘味度甘味料を含有する、請求項1~4のいずれか一項に記載の飲料組成物。
- 請求項1~5のいずれか一項に記載の飲料組成物を含有する、容器詰飲料。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201280048609.5A CN103841840B (zh) | 2011-10-07 | 2012-10-02 | 饮料组合物 |
EP12838574.7A EP2764781B9 (en) | 2011-10-07 | 2012-10-02 | Drink composition |
KR1020147008649A KR101771176B1 (ko) | 2011-10-07 | 2012-10-02 | 음료 조성물 |
US14/245,752 US20140220216A1 (en) | 2011-10-07 | 2014-04-04 | Beverage composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011223319A JP5283743B2 (ja) | 2011-10-07 | 2011-10-07 | 飲料組成物 |
JP2011-223319 | 2011-10-07 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/245,752 Continuation US20140220216A1 (en) | 2011-10-07 | 2014-04-04 | Beverage composition |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013051556A1 true WO2013051556A1 (ja) | 2013-04-11 |
Family
ID=48043713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2012/075505 WO2013051556A1 (ja) | 2011-10-07 | 2012-10-02 | 飲料組成物 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20140220216A1 (ja) |
EP (1) | EP2764781B9 (ja) |
JP (1) | JP5283743B2 (ja) |
KR (1) | KR101771176B1 (ja) |
CN (1) | CN103841840B (ja) |
WO (1) | WO2013051556A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170071232A1 (en) * | 2014-06-26 | 2017-03-16 | Fujifilm Corporation | Beverage composition |
CN115299543A (zh) * | 2022-08-12 | 2022-11-08 | 上海圣岳生物科技有限公司 | 一种促进人体多巴胺合成代谢的固体饮料及其制备方法 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104161287A (zh) * | 2014-08-29 | 2014-11-26 | 广西博士海意信息科技有限公司 | 胶原蛋白柑橘饮料及其制作方法 |
JP6647832B2 (ja) | 2015-03-13 | 2020-02-14 | サントリーホールディングス株式会社 | ノンアルコールのビールテイスト飲料 |
JP6132947B1 (ja) * | 2016-03-24 | 2017-05-24 | アサヒ飲料株式会社 | 飲料及びルテインの飲料中安定性を調節する方法 |
WO2019009251A1 (ja) * | 2017-07-03 | 2019-01-10 | 味の素株式会社 | 飲料 |
CN110944519A (zh) * | 2017-08-10 | 2020-03-31 | 雀巢产品有限公司 | 饮料 |
CN107581622A (zh) * | 2017-11-10 | 2018-01-16 | 江苏江大五棵松生物科技有限公司 | 一种具备美容养颜功效的多肽营养液 |
KR20200118187A (ko) * | 2018-02-09 | 2020-10-14 | 산토리 홀딩스 가부시키가이샤 | 콜라겐 펩티드를 포함하는 액상 경구용 조성물 및 액상 경구용 조성물의 산미를 완화하는 방법 |
WO2019232369A1 (en) * | 2018-06-01 | 2019-12-05 | Stokely-Van Camp, Inc. | Zero-sugar beverage composition |
KR20210096172A (ko) * | 2018-11-30 | 2021-08-04 | 산토리 홀딩스 가부시키가이샤 | 콜라겐 펩티드를 함유하는 액상 경구용 조성물 및 액상 경구용 조성물의 거품 발생을 억제하는 방법 |
CN111938159B (zh) * | 2020-09-01 | 2022-10-14 | 何荣光 | 一种胶原蛋白肽组合物及其口服液和制备方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05199855A (ja) | 1992-01-24 | 1993-08-10 | Kanebo Ltd | 健康飲料 |
JP2007006888A (ja) * | 2005-06-29 | 2007-01-18 | Stokely-Van Camp Inc | 後味を少なくするまたはなくすためのスポーツドリンク酸味料ブレンド |
WO2007023999A1 (ja) * | 2005-08-24 | 2007-03-01 | Ajinomoto Co., Inc. | アミノ酸含有酸性飲料及びその製造方法 |
WO2007125888A1 (ja) | 2006-04-28 | 2007-11-08 | Lion Corporation | 液体経口用組成物 |
JP2008194010A (ja) * | 2007-02-15 | 2008-08-28 | Nihon Koken Kk | コラーゲンペプチド含有組成物の製造方法および用途 |
JP2010098969A (ja) * | 2008-10-22 | 2010-05-06 | Yoshigen:Kk | 飲食品材料及びこれを用いた飲料 |
JP2011103822A (ja) | 2009-11-18 | 2011-06-02 | Fujifilm Corp | コラーゲンペプチド含有飲料 |
WO2011075527A1 (en) * | 2009-12-18 | 2011-06-23 | Stokely-Van Camp, Inc. | Protein recovery beverage |
JP2011125329A (ja) * | 2009-09-30 | 2011-06-30 | Fujifilm Corp | コラーゲンペプチド含有組成物の製造方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4377522B2 (ja) * | 2000-05-09 | 2009-12-02 | 株式会社ヤクルト本社 | 安定な酸性乳飲料、その製造方法およびこれに使用する酸性乳飲料用添加剤 |
US20030069202A1 (en) * | 2000-06-02 | 2003-04-10 | Kern Kenneth Norman | Compositions, kits, and methods for promoting defined health benefits |
US20100068342A1 (en) * | 2006-11-15 | 2010-03-18 | Meji Seika Kaisha Ltd | Collagen peptide composition and food or beverage containing the same |
WO2009126932A2 (en) * | 2008-04-10 | 2009-10-15 | Provide Nutrition | Fortified liquid protein compositions and methods of making same |
JP4428456B2 (ja) * | 2008-04-30 | 2010-03-10 | ユーハ味覚糖株式会社 | コラーゲンペプチド含有飲料及びその製造方法 |
EP2760296A2 (en) * | 2011-09-30 | 2014-08-06 | The Concentrate Manufacturing Company of Ireland | Nutrition beverages |
-
2011
- 2011-10-07 JP JP2011223319A patent/JP5283743B2/ja active Active
-
2012
- 2012-10-02 KR KR1020147008649A patent/KR101771176B1/ko active IP Right Grant
- 2012-10-02 EP EP12838574.7A patent/EP2764781B9/en not_active Not-in-force
- 2012-10-02 CN CN201280048609.5A patent/CN103841840B/zh active Active
- 2012-10-02 WO PCT/JP2012/075505 patent/WO2013051556A1/ja active Application Filing
-
2014
- 2014-04-04 US US14/245,752 patent/US20140220216A1/en not_active Abandoned
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05199855A (ja) | 1992-01-24 | 1993-08-10 | Kanebo Ltd | 健康飲料 |
JP2007006888A (ja) * | 2005-06-29 | 2007-01-18 | Stokely-Van Camp Inc | 後味を少なくするまたはなくすためのスポーツドリンク酸味料ブレンド |
WO2007023999A1 (ja) * | 2005-08-24 | 2007-03-01 | Ajinomoto Co., Inc. | アミノ酸含有酸性飲料及びその製造方法 |
WO2007125888A1 (ja) | 2006-04-28 | 2007-11-08 | Lion Corporation | 液体経口用組成物 |
JP2008194010A (ja) * | 2007-02-15 | 2008-08-28 | Nihon Koken Kk | コラーゲンペプチド含有組成物の製造方法および用途 |
JP2010098969A (ja) * | 2008-10-22 | 2010-05-06 | Yoshigen:Kk | 飲食品材料及びこれを用いた飲料 |
JP2011125329A (ja) * | 2009-09-30 | 2011-06-30 | Fujifilm Corp | コラーゲンペプチド含有組成物の製造方法 |
JP2011103822A (ja) | 2009-11-18 | 2011-06-02 | Fujifilm Corp | コラーゲンペプチド含有飲料 |
WO2011075527A1 (en) * | 2009-12-18 | 2011-06-23 | Stokely-Van Camp, Inc. | Protein recovery beverage |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170071232A1 (en) * | 2014-06-26 | 2017-03-16 | Fujifilm Corporation | Beverage composition |
CN115299543A (zh) * | 2022-08-12 | 2022-11-08 | 上海圣岳生物科技有限公司 | 一种促进人体多巴胺合成代谢的固体饮料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
JP2013081418A (ja) | 2013-05-09 |
JP5283743B2 (ja) | 2013-09-04 |
EP2764781B9 (en) | 2018-06-27 |
KR20140072882A (ko) | 2014-06-13 |
US20140220216A1 (en) | 2014-08-07 |
EP2764781A1 (en) | 2014-08-13 |
EP2764781A4 (en) | 2015-06-17 |
CN103841840A (zh) | 2014-06-04 |
EP2764781B1 (en) | 2017-12-20 |
KR101771176B1 (ko) | 2017-08-23 |
CN103841840B (zh) | 2016-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5283743B2 (ja) | 飲料組成物 | |
TWI324047B (ja) | ||
JP6918188B2 (ja) | ホエイプロテインを含む高プロテイン飲料 | |
TWI360395B (en) | Acid prothin food with mineral | |
TWI323159B (ja) | ||
JP2023052261A (ja) | 感覚変更化合物 | |
JP5283676B2 (ja) | コラーゲンペプチド含有組成物の製造方法 | |
US20130171294A1 (en) | Nutritional Compositions | |
JP5303438B2 (ja) | コラーゲンペプチド含有飲料 | |
JP2006315985A (ja) | ビタミンの劣化抑制方法 | |
JP6377431B2 (ja) | 飲料組成物 | |
JP5355809B1 (ja) | 飲料 | |
JP7197519B2 (ja) | コラーゲンペプチドを含む液状経口用組成物及びコラーゲンペプチドを含む液状経口用組成物の風味改善方法 | |
CN108497250A (zh) | 一种mct强化的乳清蛋白运动饮料及生产工艺 | |
JP2021090412A (ja) | 不快味マスキング剤、酸性タンパク質飲料、不快味マスキング方法、及び酸性タンパク質飲料の製造方法 | |
JP2015130840A (ja) | 粉末飲食品 | |
JP7154237B2 (ja) | コラーゲンペプチドを含む液状経口用組成物及び液状経口用組成物の酸味を緩和する方法 | |
JP6753255B2 (ja) | 液体栄養組成物 | |
JP7336970B2 (ja) | パフィア含有酸性飲食物 | |
US20140377441A1 (en) | Clear Protein Beverage | |
CA2820523A1 (en) | Clear protein beverage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201280048609.5 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12838574 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012838574 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20147008649 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |